Brief: Gensight Biologics Announces Publication Of Results From LUMEVOQ RESCUE Pivotal Phase III Trial

Gensight Biologics SA

13/01/2021 06:48

Jan 13 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES PUBLICATION OF RESULTS FROM
LUMEVOQ® RESCUE PIVOTAL PHASE III TRIAL IN AAO JOURNAL
OPHTHALMOLOGY®
    * BILATERAL IMPROVEMENT IN VISUAL ACUITY FROM A UNILATERAL
INJECTION OF GENE THERAPY - CONSISTENT WITH REVERSE TRIAL
FINDINGS
    * GENSISIGNIFICANT IMPROVEMENT AGAINST VISUAL ACUITY NADIR
    * TOPLINE RESULTS FOR A THIRD PHASE III TRIAL, REFLECT, ARE
EXPECTED IN Q2 2021
    * LUMEVOQ APPLICATION TO EMA: DECISION EXPECTED IN Q4 2021

Source text for Eikon:  ID:nBw6yg6sRa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))